SNF.Back to Emerging
Emerging Detail

SCTX - Scribe Therapeutics Inc.

Candidate

SNF Emerging Watchlist(TM) tracks newly public companies positioned around emerging economic themes. Inclusion reflects SNF research interest and ongoing monitoring; it is not a recommendation to buy, sell, or hold a security.

Emerging Score
80 / 100
Confidence
91%
Band
Strong Emerging Profile
Last Reviewed
Oct 23, 2026
Primary Theme
Biotechnology / Health Innovation
Exchange
Nasdaq
Current Thesis

Structural Theme Relevance

What Changed

Candidate to Candidate review completed.

Why It Matters

Structural Theme Relevance

What The Market Is Pricing In

Market Confirmation currently scores 50/100 within the Emerging Score framework.

What Could Change The Narrative

First-in-human execution for STX-1150 and proving clinical translation of the platform

SNF Lens
Signal
Structural Theme Relevance
Noise
Some evidence needs refresh context.
Confirmation
Market Confirmation 50/100
Risk
First-in-human execution for STX-1150 and proving clinical translation of the platform
Six-Family Scorecard
Structural Theme Relevance
90
Business Quality
78
Growth / Traction
84
Competitive Position
86
Financial Durability
82
Market Confirmation
50
Key Risks
First-in-human execution for STX-1150 and proving clinical translation of the platform
Cash burn, safety and future financing requirements
Evidence Quality
Active Evidence
8
Sources
6
Stale Evidence
2
Freshness
Mixed freshness
Review / Score History
Oct 23, 2026Thesis unchanged - Candidate unchanged
Oct 4, 2026Thesis strengthened - Candidate unchanged
Oct 23, 2026Score 80 / Confidence 91 / Candidate
Oct 4, 2026Score 80 / Confidence 91 / Candidate
Sep 1, 2026Score 77 / Confidence 84 / Candidate
Sources
investors.scribetx.com
company-ir - Sep 2, 2026
Open source
sec.gov
sec-filing - Jul 24, 2026
Open source
investors.scribetx.com
company-ir - May 21, 2026
Open source
stockanalysis.com
market-data - Sep 1, 2026
Open source
investors.scribetx.com
company-ir - May 18, 2026
Open source
investors.scribetx.com
company-ir - Jan 20, 2026
Open source